OptraSCAN OS-SiA Scanners and AI Platform

OptraSCAN is a digital pathology company with offices in San Jose, California and Pune, India. Its site says the company has been trusted since 2004 and offers scanners, AI diagnostics and enterprise image management.

The core OS-SiA technology scans, indexes and analyzes slides at the same time. The range includes OS-SiX, OS-Lite, OS-Ultra and OS-FLi scanners, an image management system (OptraSCAN IMS) and AI apps HistoSiA for breast IHC biomarkers, CytoSiA for cervical screening and BactoSiA for TB detection and AFB grading.

• Scanners: OS-SiX (6 slides), OS-Lite (15), OS-Ultra (80-480) and OS-FLi for fluorescence and brightfield.
• OS-SiA technology: patented simultaneous scan, index and analyze workflow.
• HistoSiA: AI analysis of breast cancer IHC biomarkers.
• CytoSiA: AI-assisted cervical cancer screening.
• BactoSiA: TB detection and AFB grading for sputum smears.
• OptraSCAN IMS: image management with e-learning and frozen section modules.

Provincial TB programs can grade AFB smears with BactoSiA. Hospital pathology labs can digitize HER2 and other IHC slides under a per-slide plan. Cervical screening centers can triage Pap smears with CytoSiA.

Scanning and analysis in one pass shortens turnaround. A pay-per-scan model removes the upfront capital purchase. TB and cervical screening apps target high-volume, resource-limited settings. The site lists CE-IVDR, ISO 13485 and CDSCO certifications.

TB and cervical cancer screening in Asia need low-cost digital microscopy and AI to offset pathologist and microscopist shortages. Vietnam is a high TB burden country and expands lab digitization, so scan-plus-AI systems with pay-per-use pricing fit public and private laboratories.

Offices: 2001 Gateway Place, San Jose, CA and Pune, Maharashtra. Site shows ISO 13485, CE-IVDR and CDSCO; in North America products are research use only. Customer logos include Government of Myanmar, CMC Vellore, Duke and Penn. Founding year not stated.